Catalyst Wire Dossier Catalyst Wire Dossier

HPV-16/18 bivalent vaccine

recombinant human papillomavirus vaccine (types 16 and 18)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPV-16/18 bivalent vaccine, covering 2016-01-05 to 2016-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine [Phase 2]

See pricing